Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Предотвращение развития гипогликемии: современные возможности - Научно-практический журнал Cardioсоматика Том 10, №3 (2019)
Предотвращение развития гипогликемии: современные возможности
Доскина Е.В., Танхилевич Б.М. Предотвращение развития гипогликемии: современные возможности. CardioСоматика. 2019; 10 (3): 65–70. DOI: 10.26442/22217185.2019.3.190501
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
В России, так же как и во всем мире, отмечается постоянное увеличение распространенности сахарного диабета (СД). Российская Федерация входит в топ 10 стран с самым высоким числом взрослого населения, больного СД. Частота развития гипогликемических состояний остается крайне высокой, несмотря на доступные методы самоконтроля гликемии и большое разнообразие сахароснижающих препаратов. Так, по данным таких исследований, как URPDS, ACCJRD, VADT, ADVANCE, частота гипогликемических состояний составляла от 0,7 до 16% в зависимости от вида терапии. Независимо от тяжести гипогликемии они приводят к снижению качества жизни больных, увеличению массы тела, развитию когнитивного дефицита и/или деменции, судорожного синдрома, сердечно-сосудистых катастроф, увеличивают частоту госпитализаций и затраты на лечение СД, а также способствуют увеличению риска травматизма. Важным инструментом в управлении СД является самоконтроль гликемии. Современные глюкометры должны отвечать потребностям пациента – быть информативными, точными, удобными в использовании. Для своевременного выявления гипогликемии большое значение имеет точность глюкометра.
Ключевые слова: сахарный диабет, гипогликемия, самоконтроль, глюкометр, глюкометр Контур Плюс Уан.
Key words: diabetes mellitus, hypoglycemia, self-monitoring, glucometer, glucose meter Contour Plus One.
Ключевые слова: сахарный диабет, гипогликемия, самоконтроль, глюкометр, глюкометр Контур Плюс Уан.
________________________________________________
Key words: diabetes mellitus, hypoglycemia, self-monitoring, glucometer, glucose meter Contour Plus One.
Полный текст
Список литературы
1. Атлас диабета IDF (7-е изд.). 2015. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas
[Atlas diabeta IDF (7-e izd.). 2015. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas (in Russian).]
2. UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998, 352 (9131): 837–53.
3. Cavalot F, Pagliarino A, Valle M et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care 2011; 34: 2237–43.
4. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233–40.
5. Guerci B, Drouin P, Grange V et al. Self-monitoring of blood glucose significantly improvesтmetabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabet Metab 2003; 29: 587–94.
6. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 671–81.
7. Martin S, Schneider B, Heinemann L et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271–8.
8. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994; 31: 215–9.
9. Sarol JN, Nicodemus NA, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004). Curr Med Res Opin 2005; 21: 173–84.
10. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Самоконтроль гликемии – неотъемлемый компонент лечения сахарного диабета. Мед. совет. 2013, 1: 90–7.
[Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Samokontrol' glikemii – neot"emlemyi komponent lecheniia sakharnogo diabeta. Med. sovet. 2013, 1: 90–7 (in Russian).]
11. Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema. Diabetes Res Clin Pract 2009; 86 (2): 104–10.
12. Action to Control Cardiovascular Risk in Diabetes Study Group. Rationale and design for the blood pressure intervention. Am J Cardiol 2007; 99 (Suppl.): 44–55.
13. Клинические рекомендации «Алгоритмы специализированной медицинской помощи больным сахарным диабетом». Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. 9-й вып. М., 2019.
[Clinical recommendations "Algorithms of specialized medical care for patients with diabetes mellitus". Pod red. I.I.Dedova, M.V.Shestakovoi, A.Iu.Maiorova. 9-i vyp. Moscow, 2019 (in Russian).]
14. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabet Care 2010; 33: 1389–94.
15. Cryer PE. Severe hypoglycemia predicts mortality in diabetes. Diabet Care 2012; 35: 1814–6.
16. Zoungas S, Patel A, Chalmers J et al. Heller Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363: 1410–8.
17. Holstein A, Patzer OM, Machalke K et al. Substantial increase in incidence of severe hypoglycemia between 1997–2000 and 2007–2010. A German longitudinal population-based study. Diabet Care 2012; 35 (5): 972–5.
18. Bremer JP, Jauch-Chara K, Hallschmid M et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabet Care 2009; 32: 1513–7.
19. Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM 1995; 88: 439–45.
20. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabet Care 2010; 33: 1389–94.
21. Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema. Diabetes Res Clin Pract 2009; 86 (2): 104–10.
22. Контур Плюс. Руководство пользователя. Байер, 2013.
[Contour Plus. User's manual. Bayer, 2013. (in Russian).]
23. Dunne N et al. Accuracy Evaluation of CONTOUR PLUS Compared With Four Blood Glucose Monitoring Systems, Diabetes Ther 2015; 6: 377–88.
2. UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998, 352 (9131): 837–53.
3. Cavalot F, Pagliarino A, Valle M et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care 2011; 34: 2237–43.
4. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233–40.
5. Guerci B, Drouin P, Grange V et al. Self-monitoring of blood glucose significantly improvesтmetabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabet Metab 2003; 29: 587–94.
6. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 671–81.
7. Martin S, Schneider B, Heinemann L et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271–8.
8. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994; 31: 215–9.
9. Sarol JN, Nicodemus NA, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004). Curr Med Res Opin 2005; 21: 173–84.
10. Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Samokontrol' glikemii – neot"emlemyi komponent lecheniia sakharnogo diabeta. Med. sovet. 2013, 1: 90–7 (in Russian).
11. Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema. Diabetes Res Clin Pract 2009; 86 (2): 104–10.
12. Action to Control Cardiovascular Risk in Diabetes Study Group. Rationale and design for the blood pressure intervention. Am J Cardiol 2007; 99 (Suppl.): 44–55.
13. Clinical recommendations "Algorithms of specialized medical care for patients with diabetes mellitus". Pod red. I.I.Dedova, M.V.Shestakovoi, A.Iu.Maiorova. 9-i vyp. Moscow, 2019 (in Russian).
14. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabet Care 2010; 33: 1389–94.
15. Cryer PE. Severe hypoglycemia predicts mortality in diabetes. Diabet Care 2012; 35: 1814–6.
16. Zoungas S, Patel A, Chalmers J et al. Heller Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363: 1410–8.
17. Holstein A, Patzer OM, Machalke K et al. Substantial increase in incidence of severe hypoglycemia between 1997–2000 and 2007–2010. A German longitudinal population-based study. Diabet Care 2012; 35 (5): 972–5.
18. Bremer JP, Jauch-Chara K, Hallschmid M et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabet Care 2009; 32: 1513–7.
19. Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM 1995; 88: 439–45.
20. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabet Care 2010; 33: 1389–94.
21. Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema. Diabetes Res Clin Pract 2009; 86 (2): 104–10.
22. Contour Plus. User's manual. Bayer, 2013. (in Russian).
23. Dunne N et al. Accuracy Evaluation of CONTOUR PLUS Compared With Four Blood Glucose Monitoring Systems, Diabetes Ther 2015; 6: 377–88.
[Atlas diabeta IDF (7-e izd.). 2015. https://www.idf.org/e-library/epidemiology-research/diabetes-atlas (in Russian).]
2. UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998, 352 (9131): 837–53.
3. Cavalot F, Pagliarino A, Valle M et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care 2011; 34: 2237–43.
4. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233–40.
5. Guerci B, Drouin P, Grange V et al. Self-monitoring of blood glucose significantly improvesтmetabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabet Metab 2003; 29: 587–94.
6. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 671–81.
7. Martin S, Schneider B, Heinemann L et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271–8.
8. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994; 31: 215–9.
9. Sarol JN, Nicodemus NA, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004). Curr Med Res Opin 2005; 21: 173–84.
10. Майоров А.Ю., Мельникова О.Г., Филиппов Ю.И. Самоконтроль гликемии – неотъемлемый компонент лечения сахарного диабета. Мед. совет. 2013, 1: 90–7.
[Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Samokontrol' glikemii – neot"emlemyi komponent lecheniia sakharnogo diabeta. Med. sovet. 2013, 1: 90–7 (in Russian).]
11. Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema. Diabetes Res Clin Pract 2009; 86 (2): 104–10.
12. Action to Control Cardiovascular Risk in Diabetes Study Group. Rationale and design for the blood pressure intervention. Am J Cardiol 2007; 99 (Suppl.): 44–55.
13. Клинические рекомендации «Алгоритмы специализированной медицинской помощи больным сахарным диабетом». Под ред. И.И.Дедова, М.В.Шестаковой, А.Ю.Майорова. 9-й вып. М., 2019.
[Clinical recommendations "Algorithms of specialized medical care for patients with diabetes mellitus". Pod red. I.I.Dedova, M.V.Shestakovoi, A.Iu.Maiorova. 9-i vyp. Moscow, 2019 (in Russian).]
14. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabet Care 2010; 33: 1389–94.
15. Cryer PE. Severe hypoglycemia predicts mortality in diabetes. Diabet Care 2012; 35: 1814–6.
16. Zoungas S, Patel A, Chalmers J et al. Heller Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363: 1410–8.
17. Holstein A, Patzer OM, Machalke K et al. Substantial increase in incidence of severe hypoglycemia between 1997–2000 and 2007–2010. A German longitudinal population-based study. Diabet Care 2012; 35 (5): 972–5.
18. Bremer JP, Jauch-Chara K, Hallschmid M et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabet Care 2009; 32: 1513–7.
19. Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM 1995; 88: 439–45.
20. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabet Care 2010; 33: 1389–94.
21. Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema. Diabetes Res Clin Pract 2009; 86 (2): 104–10.
22. Контур Плюс. Руководство пользователя. Байер, 2013.
[Contour Plus. User's manual. Bayer, 2013. (in Russian).]
23. Dunne N et al. Accuracy Evaluation of CONTOUR PLUS Compared With Four Blood Glucose Monitoring Systems, Diabetes Ther 2015; 6: 377–88.
________________________________________________
2. UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998, 352 (9131): 837–53.
3. Cavalot F, Pagliarino A, Valle M et al. Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. Diabetes Care 2011; 34: 2237–43.
4. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 1999; 22: 233–40.
5. Guerci B, Drouin P, Grange V et al. Self-monitoring of blood glucose significantly improvesтmetabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabet Metab 2003; 29: 587–94.
6. Jansen JP. Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin 2006; 22: 671–81.
7. Martin S, Schneider B, Heinemann L et al. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 2006; 49: 271–8.
8. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994; 31: 215–9.
9. Sarol JN, Nicodemus NA, Tan KM, Grava MB. Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966–2004). Curr Med Res Opin 2005; 21: 173–84.
10. Maiorov A.Iu., Mel'nikova O.G., Filippov Iu.I. Samokontrol' glikemii – neot"emlemyi komponent lecheniia sakharnogo diabeta. Med. sovet. 2013, 1: 90–7 (in Russian).
11. Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema. Diabetes Res Clin Pract 2009; 86 (2): 104–10.
12. Action to Control Cardiovascular Risk in Diabetes Study Group. Rationale and design for the blood pressure intervention. Am J Cardiol 2007; 99 (Suppl.): 44–55.
13. Clinical recommendations "Algorithms of specialized medical care for patients with diabetes mellitus". Pod red. I.I.Dedova, M.V.Shestakovoi, A.Iu.Maiorova. 9-i vyp. Moscow, 2019 (in Russian).
14. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabet Care 2010; 33: 1389–94.
15. Cryer PE. Severe hypoglycemia predicts mortality in diabetes. Diabet Care 2012; 35: 1814–6.
16. Zoungas S, Patel A, Chalmers J et al. Heller Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363: 1410–8.
17. Holstein A, Patzer OM, Machalke K et al. Substantial increase in incidence of severe hypoglycemia between 1997–2000 and 2007–2010. A German longitudinal population-based study. Diabet Care 2012; 35 (5): 972–5.
18. Bremer JP, Jauch-Chara K, Hallschmid M et al. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabet Care 2009; 32: 1513–7.
19. Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM 1995; 88: 439–45.
20. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabet Care 2010; 33: 1389–94.
21. Veterans Affairs Diabetes Trial Study Group. Ethnicity, race, and clinically significant macular edema. Diabetes Res Clin Pract 2009; 86 (2): 104–10.
22. Contour Plus. User's manual. Bayer, 2013. (in Russian).
23. Dunne N et al. Accuracy Evaluation of CONTOUR PLUS Compared With Four Blood Glucose Monitoring Systems, Diabetes Ther 2015; 6: 377–88.
Авторы
Е.В. Доскина*1, Б.М. Танхилевич2
1 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, Москва, Россия;
2 ГБУЗ «Городская клиническая больница им. С.П. Боткина» Департамента здравоохранения г. Москвы
*Evd-evd2008@yandex.ru
1 Russian Medical Academy of Continuous Professional Education, Moscow, Russia;
2 Botkin City Clinical Hospital
*Evd-evd2008@yandex.ru
1 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, Москва, Россия;
2 ГБУЗ «Городская клиническая больница им. С.П. Боткина» Департамента здравоохранения г. Москвы
*Evd-evd2008@yandex.ru
________________________________________________
1 Russian Medical Academy of Continuous Professional Education, Moscow, Russia;
2 Botkin City Clinical Hospital
*Evd-evd2008@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.
